Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 7264 on Liver Diseases, how many community diagnostic centres provide transient elastography liver scans; and what steps his Department has taken to improve early detection of liver disease in high risk groups in (a) primary and (b) community care settings.

As of 16 February 2025, 14 community diagnostic centres (CDCs) are providing transient elastography liver scans, also known as fibroscans. By 31 March 2025, one further CDC is expected to become operational and able to offer fibroscans. NHS England is taking steps to improve the early detection of liver disease in high risk groups, both in primary and community care settings.

As of the end of February 2025, the Community Liver Health Check Programme is now in place across 19 areas, helping to identify individual patients at greater risk of cirrhosis or advanced fibrosis. The programme is identifying people at high risk of hepatocellular carcinoma (HCC), and referring them into, as well as supporting them to stay in, surveillance programmes. From June 2022 to January 2025, over 93,500 fibroscans have been delivered through the pilots, with 6,421 people having enrolled into HCC surveillance.

Primary Care Liver Case Finding pilots have also been funded across 12 primary care networks, as of the end of February 2025. These pilots used primary care records to identify patients at high risk of cirrhosis, in order to offer them blood tests and fibroscans. Over 12,700 people have been tested, and 300 people have been identified as having advanced liver disease requiring cancer surveillance, since the pilot began. These pilots are now being evaluated.

The continued funding of Laboratory Information Management Systems will also be a key step in enabling the development of liver disease pathways starting in primary care, along with the use of intelligent liver function tests, which are an effective primary diagnostic test.